Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aurinia
Aurinia
Investor activism resurfaces at Aurinia after CEO’s board role, exec pay lost majority support
Fierce Pharma
Tue, 08/13/24 - 11:10 pm
Aurinia
Robert Foster
activist investors
Aurinia to cut research after sale process fails to find a buyer
BioPharma Dive
Thu, 02/15/24 - 11:24 am
Aurinia
R&D
layoffs
Aurinia Pharmaceuticals stock surges 4% on plans to pursue a possible sale
Investing.com
Thu, 06/29/23 - 11:02 pm
Aurinia
M&A
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
As GSK, Aurinia heat up the lupus nephritis category, analyst gauges doctors' first impressions
Fierce Pharma
Thu, 06/24/21 - 11:11 am
GSK
Aurinia
lupus nephritis
Benlysta
Lupkynis
FDA
FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo
RAPS.org
Thu, 01/28/21 - 10:49 am
FDA
Cabenuva
HIV
ViiV
Aurinia
Lupkynis
Merck
Verquvo
Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch
Fierce Pharma
Sat, 01/23/21 - 11:46 pm
Aurinia
FDA
Lupkynis
voclosporin
lupus nephritis
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
drug launches
Biogen
Eisai
aducanumab
efgartigimod
Argenx
Evrenzo
FibroGen
Astellas
AstraZeneca
Leqvio
Novartis
UCB Pharma
bimekizumab
Ascendis Pharma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
liso-cel
AXS-05
Axsome Therapeutics
voclosporin
Aurinia
Biogen's Possible Shopping List: 3 Companies the Biotech Might Buy
Motley Fool
Wed, 11/11/20 - 11:01 am
Biogen
M&A
Aurinia
Cassava Sciences
Heron Therapeutics
Aurinia announces FDA acceptance of NDA filing and priority review for voclosporin to treat lupus nephritis
Pharmaceutical Business Review
Wed, 07/22/20 - 10:41 am
Aurinia
voclosporin
FDA
lupus nephritis
Facing questions on patient deaths, Aurinia shares crater in wake of PhIIb
Endpoints
Mon, 08/15/16 - 10:01 am
patient deaths
patients
Aurinia
clinical trials
voclosporin
lupus